PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1661970

[Methods to decrease the blood loss during operations under hypothermia without perfusion].

V S Shchukin·E V Len'ko·S E Naumenko
View original source ↗Export metadata ↓

Abstract

The work analyzes causes of high blood loss in operations under conditions of nonperfusion deep hypothermia. It was found to be related with the division of massive adhesions in the preocclusive period and with the presence of prolonged heparinemia after occlusion. A combination of a minimal trauma of adhesions, reliable surgical hemostasis, early suturing the wound of the chest and early neutralization of activity of heparin allowed the operation blood loss to be 2.4 times less and the postoperative blood loss--2.7 times less.

Explore related subjects

Blood Loss, SurgicalHeart DiseasesHemostasis, SurgicalHumansHypothermia, InducedPerfusionThoracotomyComparative StudyEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V S Shchukin, E V Len'ko, S E Naumenko. 1991. [Methods to decrease the blood loss during operations under hypothermia without perfusion].. https://pubmed.ncbi.nlm.nih.gov/1661970/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Low molecular weight heparin in prevention of perioperative thrombosis.

OBJECTIVE: To determine whether prophylactic treatment with low molecular weight heparin reduces the incidence of thrombosis in patients who have had general or orthopaedic surgery. DESIGN: Meta-analysis of results from 52 randomised, controlled clinical studies (29 in general surgery and 23 in orthopaedic surgery) in which low molecular weight heparin was compared with placebo, dextran, or unfractionated heparin. SUBJECTS: Patients who had had general or orthopaedic surgery. INTERVENTION: Once daily injection of a low molecular weight heparin compared with placebo, dextran, or unfractionated heparin. MAIN OUTCOME MEASURES: Incidence of deep venous thrombosis, pulmonary embolism, major haemorrhages, and death. RESULTS: The results confirm that low molecular weight heparins are more efficacious for the prophylactic treatment of deep venous thrombosis than placebo (common odds ratio 0.31, 95% confidence interval 0.22 to 0.43; p < 0.001) and dextran (0.44, 0.30 to 0.65; p < 0.001). The results suggest that low molecular weight heparins are also more efficacious than unfractionated heparin (0.85, 0.74 to 0.97; p = 0.02), with no significant difference in the incidence of major haemorrhages (1.06, 0.93 to 1.20; p = 0.62). CONCLUSIONS: Low molecular weight heparins seem to have a higher benefit to risk ratio than unfractionated heparin in preventing perioperative thrombosis. However, it remains to be shown in a suitably powered clinical trial whether low molecular weight heparin reduces the risk of fatal pulmonary embolism compared with heparin.

Blood Loss, Surgical↗
PubMed1992

Autologous whole plasma fibrin gel. Intraoperative procurement.

Fibrin glue is a relatively recent addition to the armamentarium of hemostatic agents for surgical use. Its efficacy has been repeatedly demonstrated in almost all surgical disciplines and subspecialties. Its use in the United States has been limited because of the risk of viral transmission associated with the use of human plasma. Previous authors have described techniques that limit this risk, but they are frequently impractical, expensive, or cumbersome. We describe the use of patients' own fresh plasma to make fibrin gel at the operative field. It provided hemostasis at least as good as that from heterologous plasma glue in 40 cardiac surgical patients. Autologous whole plasma fibrin gel is inexpensive and safe and eliminates the risk of viral transmission associated with glue derived from heterologous donor plasma.

Blood Loss, Surgical↗